docdok.health increases safety of coronavirus vaccinations The Basel-based startup docdok.health has developed an app that aims to increase the safety and…annett02.25.2021
Hemex attracts Swiss investors A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed…martin02.11.2021
Rhizen drug secures approval in the USA The United States Food and Drug Administration has granted accelerated approval for the drug Umbralisib.…martin02.10.2021
Novaremed secures US$50 million Basel biotech Novaremed is receiving US$50 million through an agreement with an investment group. Novaremed…martin02.03.2021
Axtria driving growth from Basel The US firm Axtria has established a new office in Basel. The company offers services…martin02.01.2021
Technologiepark Basel celebrates its role as a driver of innovation The Technologiepark Basel will be ten years old in 2021. Over the past decade, it…martin01.28.2021
Basel Area has ever more to offer investors The canton of Basel-Stadt has displayed the most striking performance in the Swiss Venture Capital…martin01.28.2021
Basel researchers developing universal cancer therapy Researchers from Basel are working on the development of a therapy in which pre-prepared immune…martin01.26.2021
Opterion Health AG moving to Muttenz Opterion is moving from the canton of Obwalden to Muttenz in the canton of Basel-Landschaft…martin01.22.2021
Evolva brings natural sugar blocker to market The biotech company Evolva is introducing L-arabinose to the market. This product is a natural…martin01.21.2021